Covid: Remdesivir ‘has little or no effect’ on survival, says WHO

For its Solidarity clinical trial, the WHO tested the effects four potential treatments – remdesivir, an Ebola drug, was one, but they also looked at malaria drug hydroxychloroquine, interferon, and the HIV drug combination of lopinavir and ritonavir.

Read the full article at: